DEVELOPMENT AND CHARACTERIZATION OF NANOPARTICLE-BASED DRUG DELIVERY SYSTEMS
DOI:
https://doi.org/10.29121/shodhkosh.v5.i7.2024.6192Keywords:
Nanoparticles, Drug Delivery Systems, Targeted Therapy, Drug Release, Characterization, BiocompatibilityAbstract [English]
With the application of nanoparticles, drug delivery has enhanced so much, as the problems of conventional medicines are resolved. Problems of the normal drug formulations such as poor solubility, low absorption, rapid degradation and undesired side effects are usual. Due to their extreme smallness (1-100 nm) and high surface area nanoparticles make possible targeted and restricted release of drugs. This research synthesized nanoparticles using polymer carriers that were biodegradable, containing model drug and analyzed the size, shape, surface charge, drug loading, and release patterns of these particles. Characterization was done using tests such as DLS, SEM and zeta potential. The outcome revealed the homogenous particle size, excellent drug loading, and a low drug release over 24 hours. Nanoparticles in general enhanced drug stability and decreased side effects as well as offering targeting capabilities that were not as successful through conventional methods. In the future, a study of the animal models, long-term stability and surface modifications should be done to achieve better results.
References
Kumar, P., Sharma, S., & Reddy, L. (2017). Polymeric nanoparticles for drug delivery: Advances and challenges. Journal of Controlled Release, 245, 1–13.
Patel, M., & Singh, R. (2018). Lipid-based nanoparticles in cancer therapy. International Journal of Nanomedicine, 13, 1009–1022.
Zhang, Y., Chen, H., & Li, X. (2019). Surface modification of nanoparticles for improved drug delivery. Pharmaceutical Research, 36(5), 1–12.
Raza, K., Khan, M. A., & Ahmad, S. (2020). Characterization techniques for nanoparticle-based drug delivery systems. Journal of Nanoscience and Nanotechnology, 20(3), 1234–1248.
Mishra, P., & Jain, N. K. (2015). Nanoparticles as drug delivery systems: Current status and future prospects. Current Drug Delivery, 12(4), 367–379.
Singh, R., & Lillard, J. W. (2009). Nanoparticle-based targeted drug delivery. Experimental and Molecular Pathology, 86(3), 215–223. DOI: https://doi.org/10.1016/j.yexmp.2008.12.004
Rani, P., & Prabhu, V. (2016). Biodegradable polymeric nanoparticles for drug delivery applications. Asian Journal of Pharmaceutical Sciences, 11(6), 700–713.
Verma, A., & Garg, S. (2013). Nanoparticles in targeted drug delivery: A review. International Journal of Pharmaceutical Investigation, 3(1), 1–10.
Reddy, L., & Arias, J. L. (2007). Polymeric nanoparticles for drug delivery: Methods and applications. Current Opinion in Colloid & Interface Science, 12(3), 148–157.
Jain, R., & Mehra, N. (2015). Lipid-based nanoparticles for controlled drug delivery. International Journal of Pharmaceutical Sciences and Research, 6(12), 5025–5035.
Kumar, S., & Yadav, S. (2010). Nanoparticles for drug delivery and imaging applications. Journal of Pharmacy and Bioallied Sciences, 2(4), 262–269.
Sharma, P., & Agrawal, A. (2018). Advances in nanoparticle-based drug delivery systems. International Journal of Drug Delivery, 10(1), 1–15.
Singh, P., & Kapoor, A. (2012). Biodegradable polymeric nanoparticles in drug delivery: An overview. Asian Journal of Pharmaceutical and Clinical Research, 5(2), 5–12.
Goyal, A., & Bansal, P. (2016). Nanotechnology in drug delivery: Current and future perspectives. Journal of Drug Delivery Science and Technology, 35, 234–246.
Rani, P., & Prasad, V. (2017). Targeted drug delivery using nanoparticles: Recent advances. Indian Journal of Pharmaceutical Education and Research, 51(3), 375–386.
Choudhury, S., & Mishra, S. (2014). Nanoparticle-mediated drug delivery in cancer therapy. Asian Pacific Journal of Cancer Prevention, 15(17), 7015–7023. DOI: https://doi.org/10.7314/APJCP.2014.15.17.7015
Sharma, V., & Gupta, N. (2020). Polymeric nanoparticles: A novel approach in drug delivery. Journal of Drug Delivery and Therapeutics, 10(1), 42–50.
Riaz, M., & Khan, M. (2013). Nanoparticles as novel drug delivery systems: An overview. Asian Journal of Pharmaceutical and Clinical Research, 6(4), 1–8.
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009). Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility, and therapeutic efficacy. Advanced Drug Delivery Reviews, 61(6), 428–437. DOI: https://doi.org/10.1016/j.addr.2009.03.009
Choudhury, S., & Dutta, P. (2011). Lipid-based nanoparticles: Strategies for drug delivery. International Journal of Pharmaceutical Sciences and Research, 2(7), 1645–1654.
Rani, S., & Dahiya, S. (2012). Polymeric nanoparticles for targeted drug delivery. Journal of Nanotechnology, 2012, 1–10.
Singh, R., & Lillard, J. W. (2008). Nanoparticle-based drug delivery systems in cancer therapy. Journal of Cellular Biochemistry, 104(6), 1350–1360.
Sharma, A., & Kumar, R. (2015). Nanoparticles in targeted drug delivery: Recent advances. Current Drug Therapy, 10(2), 85–96.
Riaz, M., & Ali, M. (2016). Biodegradable nanoparticles for drug delivery applications. Journal of Drug Delivery Science and Technology, 33, 100–112.
Singh, P., & Saini, R. (2014). Role of nanoparticles in improving drug bioavailability. International Journal of Pharmaceutical Investigation, 4(2), 76–84.
Jain, N., & Kulkarni, R. (2007). Nanoparticles as carriers for drug delivery. Indian Journal of Pharmaceutical Education and Research, 41(3), 211–218.
Gupta, A., & Sharma, P. (2019). Advances in polymeric nanoparticles for drug delivery: A review. Journal of Drug Delivery Science and Technology, 51, 1–12.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dr. Archana N. Mungle, Abhijit N. Daf, Vaishali Tilakchand Parate, Dr. Akash S. Kapse

This work is licensed under a Creative Commons Attribution 4.0 International License.
With the licence CC-BY, authors retain the copyright, allowing anyone to download, reuse, re-print, modify, distribute, and/or copy their contribution. The work must be properly attributed to its author.
It is not necessary to ask for further permission from the author or journal board.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.